DBV Technologies
DBV Technologies
-3,68 %
17,55 EUR
-0,67
Kurs
17,55
Hög
18,09
Förändring
-3,68 %
Låg
17,36
Uppdaterad
2019-07-17
Öppen
18,09
Factsheet for DBV Technologies
Company Profile
Description
DBV Technologies SA is a biotechnology company that provides therapy for food and pediatric allergy patients. The company focuses on discovering, developing, manufacturing, and commercializing treatments for severe allergies in the United States and other global markets. DBV's method of delivering biologically active compounds to the immune system is through self-administered and noninvasive products. The company also explores potential applications of its platform in vaccines and other immune diseases.
Key Stats
Website: http://www.dbv-technologies.com
Headquarter country: France
Employees: 56
Market Cap (at close 16-07-2019): EUR 658M
Fiscal Year Ends: december
Stats

Stats 2018 2017 2016 2015 2014
Price/Earnings
Forward Price/Earnings
Price/Free Cash Flow
Return on Assets -95,00 -63,50 -36,30 -19,10 -28,00
Return on Equity -132,20 -79,20 -40,50 -20,40 -30,80
Return on Invested Capital -128,90 -76,00 -40,40 -20,40 -30,50
Dividend


Dividend/Share:
Ex. Dividend Date:0001-01-01
Trailing Dividend Yield:
Payout Ratio:0,00
Date Currency Amount
Income Statement

Revenue 2018 2017 2016 2015 2014
Total Revenue 0,00 0,00 0,00 0,20 0,21
Gross Profit 0,00 0,00 0,00 0,00 0,00
Gross Margin % 100,00% 100,00% 36,63% 35,33%
Operating Expenses 2018 2017 2016 2015 2014
EBITDA -163,00 -141,00 -113,00 -43,00 -23,00
Net income -166,00 -148,00 -115,00 -45,00 -24,00
Basic Earnings Per Share -5,74 -5,97 -4,68 -2,08 -1,49
Operating Income -0,17 -0,14 -0,12 -0,05 -0,02
Operating Margin % -1 217,43% -1 277,31% -22 548,51% -11 689,12%
Cash Flow

Cash Flow 2018 2017 2016 2015 2014
Operating Cash Flow -137,00 -114,00 -60,00 -27,00 -21,00
Capital Expenditures -5,00 -8,00 -8,00 -5,00 -1,00
Free Cash Flow -141,00 -122,00 -68,00 -31,00 -22,00
Balance Sheet

Assets 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Current Assets 145,47 156,87 272,18 334,89 121,57 43,82
Long Term Assets 26,28 20,94 15,32 8,39 3,85 2,42
Total Assets 171,75 177,81 287,50 343,28 125,42 46,24
Liabilities 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Total Current Liabilities 43,54 35,93 29,00 16,02 5,55 4,23
Long Term Liabilities 11,95 15,65 5,18
Total Liabilities 47,88 44,65 21,20
Equity 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Retained Earnings -166,08 -147,69 -114,53 -44,67 -24,01 -19,31
Treasury Stock
Total Stockholder Equity 121,29 129,92 242,85 322,08 115,44 40,39
Net Tangible Assets 121,26 129,80 242,75 321,98 115,42 40,33